z-logo
open-access-imgOpen Access
Effect of spironolactone therapy on the activity of the matrix metalloproteinase system in patients with heart failure after COVID-19
Author(s) -
В. И. Подзолков,
А. И. Тарзиманова,
А. Е. Брагина,
I. I. Shvedov,
E. E. Bykova,
А. А. Иванников,
S. S. Khanakyan,
A. M. Almyasheva
Publication year - 2022
Publication title -
kardiovaskulârnaâ terapiâ i profilaktika
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.158
H-Index - 16
eISSN - 2619-0125
pISSN - 1728-8800
DOI - 10.15829/1728-8800-2022-3431
Subject(s) - spironolactone , medicine , heart failure , ejection fraction , covid-19 , gastroenterology , matrix metalloproteinase , cardiology , disease , infectious disease (medical specialty)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here